Sebastian Szmit: Two Decades of Advancing Cardio-Oncology Through Research and Guidelines
Sebastian Szmit/LinkedIn

Sebastian Szmit: Two Decades of Advancing Cardio-Oncology Through Research and Guidelines

Sebastian Szmit, Chair of the Supportive Care Section of the Polish Society of Clinical-Oncology at MASCC and Head of the Department of Cardio-Oncology at the Center for Postgraduate Medical Education, shared a post on LinkedIn:

“Centrum Medycznego Kształcenia Podyplomowego highlights my 20-year activity in cardiooncology:

  •  the beginning of my cardiooncology career in 2006
  • – my first international lecture at oncology meeting in Berlin in 2009
  • – my first lecture for International Cardio-Oncology Society in Washington DC in 2013
  • – my cooperation with ESC Council of Cardio-Oncology (since 2020)

– the most important papers:  

  •  European Society of Cardiology guidelines on cardio-oncology
  • European Hematology Association (EHA) guidelines on antithrombotic therapy in thrombocytopenic cancer patients
  • cardiooncology statement published for American Cancer Society

– the most important trials:  

  •  HEART-DAPA-MM on cardioprotective role of dapagliflozin in multiple myeloma in cooperation with Teresa López Fernández – the study supported by Agencja Badań Medycznych
  • SERENITY in cooperation with Erik Klok (Leiden University Medical Center) and Professor Simon Noble – the study supported by European Commission
  • SmartCARE in cooperation with European Cancer Organisation

Thank You!”

Other Articles Featuring Sebastian Szmit on OncoDaily.